• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用自我报告的家族健康史对乳腺癌风险预测模型中的不确定性进行量化。

Uncertainty quantification in breast cancer risk prediction models using self-reported family health history.

作者信息

Pflieger Lance T, Mason Clinton C, Facelli Julio C

机构信息

Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA.

Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.

出版信息

J Clin Transl Sci. 2017 Feb;1(1):53-59. doi: 10.1017/cts.2016.9. Epub 2017 Jan 20.

DOI:10.1017/cts.2016.9
PMID:28670484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5483939/
Abstract

Family health history (FHx) is an important factor in breast and ovarian cancer risk assessment. As such, multiple risk prediction models rely strongly on FHx data when identifying a patient's risk. These models were developed using verified information and when translated into a clinical setting assume that a patient's FHx is accurate and complete. However, FHx information collected in a typical clinical setting is known to be imprecise and it is not well understood how this uncertainty may affect predictions in clinical settings. Using Monte Carlo simulations and existing measurements of uncertainty of self-reported FHx, we show how uncertainty in FHx information can alter risk classification when used in typical clinical settings. We found that various models ranged from 52% to 64% for correct tier-level classification of pedigrees under a set of contrived uncertain conditions, but that significant misclassification are not negligible. Our work implies that (i) uncertainty quantification needs to be considered when transferring tools from a controlled research environment to a more uncertain environment (i.e, a health clinic) and (ii) better FHx collection methods are needed to reduce uncertainty in breast cancer risk prediction in clinical settings.

摘要

家族健康史(FHx)是乳腺癌和卵巢癌风险评估中的一个重要因素。因此,多种风险预测模型在识别患者风险时严重依赖FHx数据。这些模型是使用经过验证的信息开发的,在转化为临床应用时,假定患者的FHx准确且完整。然而,在典型临床环境中收集的FHx信息已知是不准确的,而且这种不确定性如何影响临床环境中的预测还不太清楚。通过蒙特卡洛模拟和自我报告的FHx不确定性的现有测量方法,我们展示了在典型临床环境中使用时,FHx信息的不确定性如何改变风险分类。我们发现,在一组人为设定的不确定条件下,各种模型对系谱进行正确层级分类的比例在52%至64%之间,但显著的错误分类不可忽视。我们的工作表明:(i)当将工具从受控的研究环境转移到更不确定的环境(即健康诊所)时,需要考虑不确定性量化;(ii)需要更好的FHx收集方法来减少临床环境中乳腺癌风险预测的不确定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/615e16877630/S2059866116000091_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/b85a08315f75/S2059866116000091_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/3ee2c1d87eb1/S2059866116000091_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/615e16877630/S2059866116000091_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/b85a08315f75/S2059866116000091_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/3ee2c1d87eb1/S2059866116000091_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/6798251/615e16877630/S2059866116000091_fig3.jpg

相似文献

1
Uncertainty quantification in breast cancer risk prediction models using self-reported family health history.使用自我报告的家族健康史对乳腺癌风险预测模型中的不确定性进行量化。
J Clin Transl Sci. 2017 Feb;1(1):53-59. doi: 10.1017/cts.2016.9. Epub 2017 Jan 20.
2
Review and Comparison of Electronic Patient-Facing Family Health History Tools.面向患者的电子家庭健康史工具的综述与比较
J Genet Couns. 2018 Apr;27(2):381-391. doi: 10.1007/s10897-018-0235-7. Epub 2018 Mar 6.
3
10 years later: assessing the impact of public health efforts on the collection of family health history.十年后:评估公共卫生工作对家庭健康史收集的影响。
Am J Med Genet A. 2015 Sep;167A(9):2026-33. doi: 10.1002/ajmg.a.37139. Epub 2015 May 1.
4
5
Evaluation and comparison of hereditary Cancer guidelines in the population.人群中遗传性癌症指南的评估与比较。
Hered Cancer Clin Pract. 2021 Jul 17;19(1):31. doi: 10.1186/s13053-021-00188-9.
6
Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer.有家族史的胃癌患者的临床病理特征及生存情况:对2736例胃癌患者的大型分析
J Gastric Cancer. 2017 Jun;17(2):162-172. doi: 10.5230/jgc.2017.17.e20. Epub 2017 Jun 20.
7
Family history of coronary artery disease and adverse clinical outcomes in patients suffering from acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者的冠状动脉疾病家族史与不良临床结局
Coron Artery Dis. 2018 Dec;29(8):657-662. doi: 10.1097/MCA.0000000000000667.
8
Compatibility of Family History Cancer Guidelines With Meaningful Use Standards.家族病史癌症指南与有意义使用标准的兼容性。
JCO Clin Cancer Inform. 2017;1. doi: 10.1200/CCI.17.00076. Epub 2017 Nov 7.
9
User experience of a family health history chatbot: A quantitative analysis.家庭健康史聊天机器人的用户体验:一项定量分析。
Res Sq. 2023 May 3:rs.3.rs-2886804. doi: 10.21203/rs.3.rs-2886804/v1.
10
User experience of a family health history chatbot: A quantitative analysis.用户对家庭健康史聊天机器人的体验:一项定量分析。
Health Informatics J. 2024 Apr-Jun;30(2):14604582241262251. doi: 10.1177/14604582241262251.

引用本文的文献

1
The IHI Rochester Report 2022 on Healthcare Informatics Research: Resuming After the CoViD-19.2022年国际医疗保健信息学会罗切斯特报告:新冠疫情后的恢复
J Healthc Inform Res. 2023 May 1;7(2):169-202. doi: 10.1007/s41666-023-00126-5. eCollection 2023 Jun.
2
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.预测对侧乳腺癌:20 个国际队列中风险计算器的外部验证。
Breast Cancer Res Treat. 2020 Jun;181(2):423-434. doi: 10.1007/s10549-020-05611-8. Epub 2020 Apr 11.
3
Compatibility of Family History Cancer Guidelines With Meaningful Use Standards.

本文引用的文献

1
Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.遗传性风险预测模型BRCAPRO的近期改进
Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015.
2
Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters.高危家族中家族癌症史数据的验证:癌症部位、种族、亲属关系程度和多个家族报告者的影响。
Am J Epidemiol. 2015 Feb 1;181(3):204-12. doi: 10.1093/aje/kwu258. Epub 2015 Jan 7.
3
Recent BRCAPRO upgrades significantly improve calibration.
家族病史癌症指南与有意义使用标准的兼容性。
JCO Clin Cancer Inform. 2017;1. doi: 10.1200/CCI.17.00076. Epub 2017 Nov 7.
最近BRCAPRO的升级显著改善了校准。
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1689-95. doi: 10.1158/1055-9965.EPI-13-1364. Epub 2014 Jun 2.
4
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.BOADICEA 乳腺癌风险预测模型:癌症发病率、肿瘤病理学和网络界面更新。
Br J Cancer. 2014 Jan 21;110(2):535-45. doi: 10.1038/bjc.2013.730. Epub 2013 Dec 17.
5
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.该使用哪种风险模型?ACS MRI 筛查指南的临床意义。
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):146-9. doi: 10.1158/1055-9965.EPI-12-0570. Epub 2012 Oct 23.
6
Bias in the reporting of family history: implications for clinical care.家族史报告中的偏差:对临床护理的影响。
J Genet Couns. 2012 Aug;21(4):547-56. doi: 10.1007/s10897-011-9470-x. Epub 2012 Jan 12.
7
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).BRCA1 和 BRCA2 基因突变携带者的乳腺癌和卵巢癌病理学:BRCA1/2 修饰因子调查员联合会(CIMBA)的研究结果。
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47. doi: 10.1158/1055-9965.EPI-11-0775. Epub 2011 Dec 5.
8
Clinical assessment of breast cancer risk based on family history.基于家族史的乳腺癌风险临床评估。
J Natl Compr Canc Netw. 2010 Oct;8(10):1148-55. doi: 10.6004/jnccn.2010.0084.
9
Introduction To Monte Carlo Simulation.蒙特卡罗模拟简介
AIP Conf Proc. 2010 Jan 5;1204:17-21. doi: 10.1063/1.3295638.
10
Comparing breast cancer risk assessment models.比较乳腺癌风险评估模型。
J Natl Cancer Inst. 2010 May 19;102(10):665-8. doi: 10.1093/jnci/djq141. Epub 2010 Apr 28.